Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease

British Journal of Dermatology

Volumn 147, Issue 4, 2002, Pages 797-800

  Nijsten, T E C ^a   Meuleman, L ^a   Lambert, Julien ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Beh et's disease; Chronic; Dapsone; Neutrophilic eccrine hidradenitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; DAPSONE; PARACETAMOL;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEADACHE; HIDRADENITIS; HISTOLOGY; HUMAN; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHCET SYNDROME; CHRONIC DISEASE; DAPSONE; FEMALE; HIDRADENITIS; HUMANS; MIDDLE AGED; PRURITUS;

EID: 0036405041     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04926.x     Document Type: Article

References (17)

1. Harrist T, Fine J, Berman R et al. Neutrophilic eccrine hidradenitis: A distinct type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 1982; 118: 263-6.
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341: 1284-91.
3. Margo CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol 1995; 34: 159-65.
4. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 28: 2444-55.
5. Kuttner BJ, Kurban RS. Neutrophilic eccrine hidradenitis in the absence of an underlying malignancy. Cutis 1988; 41: 403-5.
6. Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol 1998; 38: 1-17.
7. Gross PR, Margolis D. Neutrophilic dermatosis versus neutrophilic eccrine hidradenitis. N Engl J Med 1999; 340: 1371.
8. Moreno A, Barnadas MA, Ravella A, De Moragas JM. Infectious eccrine hidradenitis in a patient undergoing hemodialysis. Arch Dermatol 1985; 121: 1106-7.
9. Combemale P, Faisant M, Azoulay-Petit C et al. Neutrophilic eccrine hidradenitis secondary to infection with Serratia marcescens. Br J Dermatol 2000; 142: 784-8.
10. Bachmeyer C, Reygane P, Aractingi S. Recurrent neutrophilic eccrine hidradenitis in an HIV-1-infected patient. Dermatology 2000; 200: 328-30.
11. Krischer J, Rutschmann O, Roten SV et al. Neutrophilic eccrine hidradenitis in a patient with AIDS. J Dermatol 1998; 25: 199-200.
12. Sevila A, Morell A, Banuls J et al. Neutrophilic eccrine hidradenitis in an HIV-infected patient. Int J Dermatol 1996; 35: 651-2.
13. Bachmeyer C, Chaibi P, Aractingi S. Neutrophilic eccrine hidradenitis induced by granulocyte colony-stimulating factor. Br J Dermatol 1998; 139: 354-5.
14. Manganoni AM, Facchetti F, Gavazzoni R et al. Neutrophilic eccrine hidradenitis in a healthy woman. Dermatology 1994; 189: 211-12.
15. O'Neill TW, Rigby AS, Silman AJ, Barnes C. Validation of the International Study Group for Behçet's Disease. Br J Rheumatol 1994; 33: 115-17.
16. Munoz-Medina L, Callejas-Rubio JL, Troncoso-Garcia E, Ortego-Centeno N. Utility of HLA typing in the differential diagnosis of severe aphthosis and Behçet's disease. Dermatology 2000; 201: 280-1.
17. Shear NH, Knowles SR, Shapiro L, Poldre P. Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. J Am Acad Dermatol 1996; 35: 819-22.